Work

Substance Use in Persons With Schizophrenia

Year: 2006

Type: article

Source: The Journal of Nervous and Mental Disease

DOI: 10.1097/01.nmd.0000202575.79453.6e

Authors: Marvin S. Swartz, H Ryan Wagner, Jeffrey W. Swanson, T Scott Stroup, Joseph P. McEvoy, Jose M. Canive, Del D. Miller, Fred Reimherr, Mark McGee, Ahsan Khan, Richard Van Dorn, Robert A. Rosenheck, Jeffrey A. Lieberman

Institutions: Duke University, Yale University, Duke Medical Center, University of North Carolina at Chapel Hill, New York State Psychiatric Institute, Columbia University, University of New Mexico, Raymond G. Murphy VA Medical Center, University of Iowa, University of Utah

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Eli Lilly and Company, Pfizer, University of Missouri, National Institutes of Health, National Institute of Mental Health

Awards: G1121004391, CLINICAL ANTIPSYCHOTIC TRIALS OF INTERVENTION EFFECTIVES

OpenAlex ID: W2093348590

FWCI: 10.6

Cites: 37

Cited by: 146

Related to: 10